| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/13/2004 | WO2004014917A3 Antitumoral analogs of lamellarins |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | WO2004002476A3 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 05/13/2004 | WO2002064735A3 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092744 Process for preparing crystalline form I of cabergoline |
| 05/13/2004 | US20040092726 Rare earth metal salt complexed with macropolycyclic compound |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/13/2004 | US20040092573 Anticholesterol agents |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092559 Bicyclic modulators of androgen receptor function |
| 05/13/2004 | US20040092547 Alkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines |
| 05/13/2004 | US20040092546 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092538 Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives |
| 05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
| 05/13/2004 | US20040092534 Orally administering a capsule shaped tablet core dosage form containing paliperidone, releases paliperidone an ascending release rate form a prolonged period of time |
| 05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040091530 Dosage forms for oral admistration resulting in a maximum secretagogue plasma concentration, Cmax, less than 80% Cmax of that when an equal dose is administered in an immediate release form; osmotic tablet of a asymetric membrane; 6 hours |
| 05/13/2004 | US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy. |
| 05/13/2004 | DE10332232A1 Heteroaryloxy-substituierte Phenylaminopyrimidine Heteroaryloxyphenoxyalkanecarboxylic substituted Phenylaminopyrimidine |
| 05/13/2004 | DE10250082A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | CA2503119A1 Anti-infective biaryl compounds |
| 05/13/2004 | CA2500487A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 05/13/2004 | CA2485343A1 Mitotic kinesin inhibitors |
| 05/12/2004 | EP1418175A1 Respiratory syncytial virus replication inhibitors |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417208A1 Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| 05/12/2004 | EP1417207A2 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |
| 05/12/2004 | CN1496361A 苯基衍生物3 Phenyl derivative 3 |
| 05/12/2004 | CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof |
| 05/12/2004 | CN1496259A New use |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1494903A Preventing or curing agent for eye fatigue and pseudomyopia |
| 05/12/2004 | CN1149214C Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149192C Process for preparing protected 4-aminomethyl-pyrrolidin-3-one |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
| 05/11/2004 | US6734190 Dihydrodipyrazolopyridinylbenzamide and -sulfonamide inhibitors of B7-1 |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 05/06/2004 | WO2004037831A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037822A1 7-phenyl pyrazolopyridine compounds |
| 05/06/2004 | WO2004037821A1 Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, preparation thereof and application of same in therapeutics |
| 05/06/2004 | WO2004037814A1 Indazolinone compositions useful as kinase inhibitors |
| 05/06/2004 | WO2004037811A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037810A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037213A2 Nuclear hormone receptor compounds, products and methods employing same |
| 05/06/2004 | WO2004037176A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 05/06/2004 | WO2004013143A3 Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands |
| 05/06/2004 | WO2003097641A3 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2001072754A9 Alkylated imidazopyridine derivatives |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087794 Alpha bromination of p-(3-(dimethylaminocarbonyl)propionyl)-toluene |
| 05/06/2004 | US20040087641 Spiropyrazole compounds |
| 05/06/2004 | US20040087616 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 05/06/2004 | US20040087615 Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087589 Controlling elimination of corticotropin releasing factor; stroke therapy |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | US20040087577 Anti-infective agents |
| 05/06/2004 | US20040087574 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/06/2004 | US20040087570 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040086745 Emits bluish light with a high purity of color |
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1415990A1 Diazepan derivatives useful as factor X inhibitor |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1414912A2 Perylene pigment compositions |
| 05/06/2004 | EP1414830A1 Tumour inhibiting lanthane compounds |
| 05/06/2004 | EP1414829A2 Tumour inhibiting cerium compounds |
| 05/06/2004 | EP1414821A1 Tricyclic epoxides |
| 05/06/2004 | EP1414820A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/06/2004 | EP1414819A1 THERAPEUTIC 1H-PYRIDO 4,3-b]INDOLES |
| 05/06/2004 | EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | EP1414464A2 Method for treating glaucoma v |
| 05/06/2004 | EP1414449A2 Bicyclic inhibitors of factor xa |
| 05/06/2004 | EP1414443A1 BENZIMIDAZO 4,5-f]ISOQUINOLINONE DERIVATIVES |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |